SAFETY AND EFFICACY OF TWO DOSES OF ATIR101, A T-LYMPHOCYTE ENRICHED LEUKOCYTE PREPARATION DEPLETED OF HOST ALLOREACTIVE T-CELLS, IN PATIENTS WITH A HEMATOLOGIC MALIGNANCY WHO RECEIVED A HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM A HAPLOIDENTICAL DONOR: